Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. With a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, Scinai offers end-to-end boutique CDMO services in parallel to developing its own pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized VHH antibody (NanoAb) pipeline targeting diseases with large unmet medical needs. Company website: www.scinai.com
View Top Employees from Scinai Immunotherapeutics Ltd.Website | http://www.scinai.com |
Employees | 39 (9 on RocketReach) |
Industry | Biotechnology Research |
Looking for a particular Scinai Immunotherapeutics Ltd. employee's phone or email?
Elad Mark is the COO of Scinai Immunotherapeutics Ltd..
9 people are employed at Scinai Immunotherapeutics Ltd..